Abstract:We present a novel computational method for predicting which proteins from highly and abnormally expressed genes in diseased human tissues, such as cancers, can be secreted into the bloodstream, suggesting possible marker proteins for follow-up serum proteomic studies. A main challenging issue in tackling this problem is that our understanding about the downstream localization after proteins are secreted outside the cells is very limited and not sufficient to provide useful hints about secretion to the bloodstream. To bypass this difficulty, we have taken a data mining approach by first collecting, through extensive literature searches, human proteins that are known to be secreted into the bloodstream due to various pathological conditions as detected by previous proteomic studies, and then asking the question: 'what do these secreted proteins have in common in terms of their physical and chemical properties, amino acid sequence and structural features that can be used to predict them?' We have identified a list of features, such as signal peptides, transmembrane domains, glycosylation sites, disordered regions, secondary structural content, hydrophobicity and polarity measures that show relevance to protein secretion. Using these features, we have trained a support vector machine-based classifier to predict protein secretion to the bloodstream. On a large test set containing 98 secretory proteins and 6601 non-secretory proteins of human, our classifier achieved approximately 90% prediction sensitivity and approximately 98% prediction specificity. Several additional datasets are used to further assess the performance of our classifier. On a set of 122 proteins that were found to be of abnormally high abundance in human blood due to various cancers, our program predicted 62 as blood-secreted proteins. By applying our program to abnormally highly expressed genes in gastric cancer and lung cancer tissues detected through microarray gene expression studies, we predicted 13 and 31 as blood secreted, respectively, suggesting that they could serve as potential biomarkers for these two cancers, respectively. Our study demonstrated that our method can provide highly useful information to link genomic and proteomic studies for disease biomarker discovery. Our software can be accessed at http://csbl1.bmb.uga.edu/cgi-bin/Secretion/secretion.cgi.

Human Body-Fluid Proteome: Quantitative Profiling and Computational Prediction.

Deep Dive on the Proteome of Human Body Fluids: A Valuable Data Resource for Biomarker Discovery.

A Comparative Proteomics Analysis of Five Body Fluids: Plasma, Urine, Cerebrospinal Fluid, Amniotic Fluid, and Saliva

HBFP: a New Repository for Human Body Fluid Proteome.

Prediction of Body Fluids Where Proteins Are Secreted into Based on Protein Interaction Network.

Enhanced Detection of Low Abundance Human Plasma Proteins Using a Tandem IgY12-SuperMix Immunoaffinity Separation Strategy

DeepSec: a deep learning framework for secreted protein discovery in human body fluids

Recent Advances in Proteomics: Towards the Human Proteome.

Proteomic Technology and Its Biomedical Applications.

In-Depth Blood Proteome Profiling by Extensive Fractionation and Multiplexed Quantitative Mass Spectrometry

Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications

[Progress in Human Disease Proteomics].

Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification

Prediction of Secreted Proteins in Human Body Fluids Using Protein Language Models and Attention

Recent research on optimized mass spectrum analysis of human body fluids peptidome

The Future of Large-Scale Collaborative Proteomics Biomarkers, That Indicate the Nature of Biological Processes and Drug Responses, Promise Early Diagnoses and Faster Discovery of New Drugs.

Computational Prediction of Human Proteins That Can Be Secreted into the Bloodstream.

Recent progress in mass spectrometry proteomics for biomedical research

Proteomic Profiling of Human Plasma for Cancer Biomarker Discovery

Bioinformatic Application in Proteomic Research on Biomarker Discovery and Drug Target Validation

Recent Progress of Proteomics-driven Precision Medicine